125 related articles for article (PubMed ID: 36319848)
1. Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study.
Egger S; Smith DP; Patel MI; Kimlin MG; Armstrong BK; Nair-Shalliker V
Br J Cancer; 2023 Jan; 128(1):71-79. PubMed ID: 36319848
[TBL] [Abstract][Full Text] [Related]
2. Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study.
Nair-Shalliker V; Bang A; Egger S; Yu XQ; Chiam K; Steinberg J; Patel MI; Banks E; O'Connell DL; Armstrong BK; Smith DP
Br J Cancer; 2022 Sep; 127(4):735-746. PubMed ID: 35610365
[TBL] [Abstract][Full Text] [Related]
3. Association Between Health Maintenance Practices and Skin Cancer Risk as a Possible Source of Detection Bias.
Drucker AM; Li WQ; Savitz DA; Weinstock MA; Han J; Li T; Qureshi AA; Cho E
JAMA Dermatol; 2019 Mar; 155(3):353-357. PubMed ID: 30586131
[TBL] [Abstract][Full Text] [Related]
4. An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: Results from the New South Wales Cancer Registry.
Cole-Clark D; Nair-Shalliker V; Bang A; Rasiah K; Chalasani V; Smith DP
Sci Rep; 2018 May; 8(1):7167. PubMed ID: 29740153
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors Associated With First and Second Primary Melanomas in a High-Incidence Population.
Olsen CM; Pandeya N; Dusingize JC; Neale RE; MacGregor S; Law MH; Whiteman DC;
JAMA Dermatol; 2023 Jan; 159(1):37-46. PubMed ID: 36416830
[TBL] [Abstract][Full Text] [Related]
6. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.
Pron G
Ont Health Technol Assess Ser; 2015; 15(10):1-64. PubMed ID: 26366236
[TBL] [Abstract][Full Text] [Related]
7. The effect of screening on melanoma incidence and biopsy rates.
Whiteman DC; Olsen CM; MacGregor S; Law MH; Thompson B; Dusingize JC; Green AC; Neale RE; Pandeya N;
Br J Dermatol; 2022 Oct; 187(4):515-522. PubMed ID: 35531668
[TBL] [Abstract][Full Text] [Related]
8. Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.
Arnsrud Godtman R; Holmberg E; Lilja H; Stranne J; Hugosson J
Eur Urol; 2015 Sep; 68(3):354-60. PubMed ID: 25556937
[TBL] [Abstract][Full Text] [Related]
9. Biochemical recurrence after radical prostatectomy for prevalent versus incident cases of prostate cancer : implications for management.
Nguyen PL; Chen MH; Catalona WJ; Alexander BM; Roehl KA; Loeb S; D'Amico AV
Cancer; 2008 Dec; 113(11):3146-52. PubMed ID: 18932254
[TBL] [Abstract][Full Text] [Related]
10. Number of Screening Rounds and Postscreening Prostate Cancer Incidence: Results from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer Study.
Pakarainen T; Raitanen J; Talala K; Taari K; Kujala P; Tammela TL; Auvinen A
Eur Urol; 2016 Sep; 70(3):499-505. PubMed ID: 27210461
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study.
Nair-Shalliker V; Bang A; Weber M; Goldsbury DE; Caruana M; Emery J; Banks E; Canfell K; O'Connell DL; Smith DP
Sci Rep; 2018 Mar; 8(1):4261. PubMed ID: 29523809
[TBL] [Abstract][Full Text] [Related]
12. Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study.
Crump C; Stattin P; Brooks JD; Sundquist J; Edwards AC; Sieh W; Sundquist K
JNCI Cancer Spectr; 2023 Jul; 7(4):. PubMed ID: 37389442
[TBL] [Abstract][Full Text] [Related]
13. Skin Melanoma and Subsequent Risk of Prostate Cancer: A Lithuanian Cancer Registry Study.
Patasius A; Urbonas V; Smailyte G
Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31618913
[TBL] [Abstract][Full Text] [Related]
14. The diagnosis and initial management of melanoma in Australia: findings from the prospective, population-based QSkin study.
Pandeya N; Olsen CM; Shalit MM; Dusingize JC; Neale RE; Whiteman DC
Med J Aust; 2023 May; 218(9):402-407. PubMed ID: 37041657
[TBL] [Abstract][Full Text] [Related]
15. Characteristics Associated with the Use of Diagnostic Prostate Biopsy and Biopsy Outcomes in Australian Men.
Chiam K; Bang A; Patel MI; Nair-Shalliker V; O'Connell DL; Smith DP
Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1735-1743. PubMed ID: 34155065
[TBL] [Abstract][Full Text] [Related]
16. Cancer screening in Queensland men.
Carrière P; Baade P; Newman B; Aitken J; Janda M
Med J Aust; 2007 Apr; 186(8):404-7. PubMed ID: 17437394
[TBL] [Abstract][Full Text] [Related]
17. Poor Follow-up After Elevated Prostate-specific Antigen Tests: A Population-based Cohort Study.
Aly M; Clements M; Weibull CE; Nordström T; Näslund E; Adolfsson J; Grönberg H
Eur Urol Focus; 2019 Sep; 5(5):842-848. PubMed ID: 29433987
[TBL] [Abstract][Full Text] [Related]
18. Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality.
Hugosson J; Godtman RA; Carlsson SV; Aus G; Grenabo Bergdahl A; Lodding P; Pihl CG; Stranne J; Holmberg E; Lilja H
Scand J Urol; 2018 Feb; 52(1):27-37. PubMed ID: 29254399
[TBL] [Abstract][Full Text] [Related]
19. The Finnish prostate cancer screening trial: analyses on the screening failures.
Kilpeläinen TP; Tammela TL; Malila N; Hakama M; Santti H; Määttänen L; Stenman UH; Kujala P; Auvinen A
Int J Cancer; 2015 May; 136(10):2437-43. PubMed ID: 25359457
[TBL] [Abstract][Full Text] [Related]
20. Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort study.
Thomsen FB; Folkvaljon Y; Garmo H; Robinson D; Loeb S; Ingvar C; Lambe M; Stattin P
Int J Cancer; 2016 May; 138(9):2154-60. PubMed ID: 26662367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]